Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Entellus Medical (ENTL)

Entellus Medical (ENTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Entellus Medical 3600 HOLLY LANE NORTH SUITE 40 PLYMOUTH MN 55447 USA

www.entellusmedical.com P: 763-463-1595

Description:

Entellus Medical, Inc. is a medical technology company. It is engaged in the designing, development and commercialization of products for the treatment of chronic sinusitis. The company operates primarily in the United States and Canada. Entellus Medical, Inc. is headquartered in Plymouth, Minnesota.

Key Statistics

Overview:

Market Capitalization, $K 617,520
Shares Outstanding, K 25,730
Annual Sales, $ 75,180 K
Annual Net Income, $ -28,720 K
Last Quarter Sales, $ 23,330 K
Last Quarter Net Income, $ -3,240 K
60-Month Beta -0.02
% of Insider Shareholders 7.70%
% of Institutional Shareholders 83.44%

Growth:

1-Year Return 65.18%
3-Year Return 11.84%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/01/17
Next Earnings Date 03/06/18
Earnings Per Share ttm -1.65
EPS Growth vs. Prev Qtr -32.43%
EPS Growth vs. Prev Year 2.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ENTL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -47.37%
Return-on-Assets % -27.29%
Profit Margin % -38.20%
Debt/Equity N/A
Price/Sales 7.16
Price/Cash Flow N/A
Price/Book 4.91
Book Value/Share 4.89
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar